Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
139
-
Total 13F shares, excl. options
-
60.5M
-
Shares change
-
+544K
-
Total reported value, excl. options
-
$134M
-
Value change
-
+$1.1M
-
Put/Call ratio
-
0.92
-
Number of buys
-
81
-
Number of sells
-
-45
-
Price
-
$2.21
Significant Holders of Xeris Biopharma Holdings, Inc. - COM (XERS) as of Q1 2024
155 filings reported holding XERS - Xeris Biopharma Holdings, Inc. - COM as of Q1 2024.
Xeris Biopharma Holdings, Inc. - COM (XERS) has 139 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 60.5M shares
.
Largest 10 shareholders include BlackRock Inc. (9.96M shares), VANGUARD GROUP INC (7.61M shares), CAXTON CORP (5.11M shares), MPM BIOIMPACT LLC (4.17M shares), STATE STREET CORP (3.22M shares), GEODE CAPITAL MANAGEMENT, LLC (3.05M shares), Rosalind Advisors, Inc. (2.82M shares), MILLENNIUM MANAGEMENT LLC (1.7M shares), Nuveen Asset Management, LLC (1.59M shares), and CenterBook Partners LP (1.54M shares).
This table shows the top 139 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.